Cardiovascular disease, particularly coronary artery disease (CAD), remains a predominant
cause of mortality globally. Factors such as atherosclerosis and inflammation play significant …

Background The inflammatory response occurring in acute myocardial infarction (AMI) has
been proposed as a potential pharmacological target. Sodium-glucose co-transporter 2 …

Stroke constitutes the primary source of adult functional disability, exhibiting a paramount
socioeconomic burden. Thus, it is of great importance that the prediction of stroke outcome …

Background Hyperglycemia has been associated with increased inflammatory indexes and
larger infarct sizes in patients with obstructive acute myocardial infarction (obs-AMI). In …

Background Myocarditis attributable to immune checkpoint inhibitor (ICI) therapy is a
potentially fatal immune‐related adverse event. Limited data have suggested an association …

Background Inflammation plays a key role in the development of atherosclerosis and in the
pathogenesis of acute coronary syndrome (ACS). Leukocytes and leukocytes ratios were …

Background: The systemic immune-inflammation index (SII) has been reported as a new
prognostic marker in tumors and cardiovascular diseases Objective: To investigate the …

Background SGTL2-inhibitors are a cornerstone in the treatment of heart failure, but data on
patients with acute myocardial infarction (AMI) is limited. The EMMY trial was the first to …

Background Inflammation may mediate response to acute reperfusion therapy (RT) in acute
cerebral ischaemia. Neutrophil-lymphocyte ratio (NLR), an inflammatory biomarker, may …

The systemic immune-inflammation index (SII) and systemic inflammation response index
(SIRI) have previously demonstrated predictive value in coronary artery disease (CAD). We …